A. Boutan-Laroze

Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.

M. Buyse, O. Bouché, P. Piedbois, 2001, Seminars in oncology.

Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.

J. Droz, J. Kattan, V. Ribrag, 1992, European journal of cancer.

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience.

J. Droz, M. Spielmann, P. Fargeot, 1991, European journal of cancer.

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

P. Couvreur, P. Rougier, J. Droz, 1992, Investigational New Drugs.

Ovarian dysgerminoma metastatic to the breast.

J. Droz, J. Kattan, P. Charpentier, 1992, Gynecologic oncology.

Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.

R. Ginsberg, Y. Cormier, R. Feld, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

M. Buyse, O. Bouché, A. de Gramont, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial.

Marc Buyse, Pascal Piedbois, Thierry Andre, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Adjuvant treatment of colon cancer MOSAIC study's main results].

C. Tournigand, A. de Gramont, T. André, 2006, Bulletin du cancer.

High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.

S. Culine, J. Droz, J. Kattan, 1993, European journal of cancer.

Feasibility trial of a combination of vinorelbine, ifosfamide, fluorouracil and folinic acid (VIF regimen) in advanced urothelial cancer.

C. Théodore, J. Droz, J. Kattan, 1993, European journal of cancer.